相似文献
1
Mutations within the rplD Gene of Linezolid-Nonsusceptible Streptococcus pneumoniae Strains Isolated in the United States.
Antimicrob Agents Chemother. 2014;58(4):2459-62. doi: 10.1128/AAC.02630-13. Epub 2014 Feb 3.
2
In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
Antimicrob Agents Chemother. 2004 Aug;48(8):3169-71. doi: 10.1128/AAC.48.8.3169-3171.2004.
3
Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance.
Genome Res. 2009 Jul;19(7):1214-23. doi: 10.1101/gr.089342.108. Epub 2009 Apr 6.
4
Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations.
BMC Genomics. 2011 Oct 17;12:512. doi: 10.1186/1471-2164-12-512.
5
Molecular characterization of linezolid-resistant CoNS isolates in Japan.
J Antimicrob Chemother. 2015 Mar;70(3):658-63. doi: 10.1093/jac/dku443. Epub 2014 Nov 6.
6
In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides.
J Antimicrob Chemother. 2005 Oct;56(4):633-42. doi: 10.1093/jac/dki301. Epub 2005 Aug 31.
7
LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States.
Antimicrob Agents Chemother. 2011 Aug;55(8):3684-90. doi: 10.1128/AAC.01729-10. Epub 2011 Jun 13.
8
Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
Antimicrob Agents Chemother. 2009 Dec;53(12):5265-74. doi: 10.1128/AAC.00871-09. Epub 2009 Sep 14.
9
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2273-80. doi: 10.1128/AAC.02803-15. Print 2016 Apr.
10
Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations.
Antimicrob Agents Chemother. 2013 Aug;57(8):4082-3. doi: 10.1128/AAC.00437-13. Epub 2013 May 20.
引用本文的文献
1
In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China.
Infect Drug Resist. 2021 Nov 9;14:4689-4697. doi: 10.2147/IDR.S332835. eCollection 2021.
2
Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.
J Antimicrob Chemother. 2019 Dec 1;74(12):3445-3452. doi: 10.1093/jac/dkz367.
3
A Mechanism of Unidirectional Transformation, Leading to Antibiotic Resistance, Occurs within Nasopharyngeal Pneumococcal Biofilm Consortia.
mBio. 2018 May 15;9(3):e00561-18. doi: 10.1128/mBio.00561-18.
4
Antimicrobial resistance mechanisms and potential synthetic treatments.
Future Sci OA. 2018 Feb 5;4(4):FSO290. doi: 10.4155/fsoa-2017-0109. eCollection 2018 Apr.
5
Five-Year Summary of Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015).
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00609-17. Print 2017 Jul.
6
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.
Clin Microbiol Rev. 2016 Jul;29(3):525-52. doi: 10.1128/CMR.00058-15.
7
Tedizolid Phosphate: a Next-Generation Oxazolidinone.
Infect Dis Ther. 2015 Feb 24;4(1):1-14. doi: 10.1007/s40121-015-0060-3.
8
Mobile elements and chromosomal changes associated with MLS resistance phenotypes of invasive pneumococci recovered in the United States.
Microb Drug Resist. 2015 Apr;21(2):121-9. doi: 10.1089/mdr.2014.0086. Epub 2014 Aug 12.
9
220D-F2 from Rubus ulmifolius kills Streptococcus pneumoniae planktonic cells and pneumococcal biofilms.
PLoS One. 2014 May 13;9(5):e97314. doi: 10.1371/journal.pone.0097314. eCollection 2014.
本文引用的文献
1
First report of the multiresistance gene cfr in Streptococcus suis.
Antimicrob Agents Chemother. 2013 Aug;57(8):4061-3. doi: 10.1128/AAC.00713-13. Epub 2013 Jun 3.
2
Linezolid surveillance results for the United States: LEADER surveillance program 2011.
Antimicrob Agents Chemother. 2013 Feb;57(2):1077-81. doi: 10.1128/AAC.02112-12. Epub 2012 Dec 17.
3
Resistance to linezolid caused by modifications at its binding site on the ribosome.
Antimicrob Agents Chemother. 2012 Feb;56(2):603-12. doi: 10.1128/AAC.05702-11. Epub 2011 Dec 5.
4
Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program.
Diagn Microbiol Infect Dis. 2010 Dec;68(4):459-67. doi: 10.1016/j.diagmicrobio.2010.09.018.
5
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy.
J Antimicrob Chemother. 2010 Nov;65(11):2329-35. doi: 10.1093/jac/dkq331. Epub 2010 Sep 14.
6
Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
Clin Infect Dis. 2010 Mar 15;50(6):821-5. doi: 10.1086/650574.
7
Polyphyletic emergence of linezolid-resistant staphylococci in the United States.
Antimicrob Agents Chemother. 2010 Feb;54(2):742-8. doi: 10.1128/AAC.00621-09. Epub 2009 Nov 23.
8
Linezolid surveillance program results for 2008 (LEADER Program for 2008).
Diagn Microbiol Infect Dis. 2009 Dec;65(4):392-403. doi: 10.1016/j.diagmicrobio.2009.10.011.
9
Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit.
Eur J Clin Microbiol Infect Dis. 2010 Jan;29(1):73-80. doi: 10.1007/s10096-009-0823-4. Epub 2009 Oct 30.
10
Linezolid: a review of safety and tolerability.
J Infect. 2009 Sep;59 Suppl 1:S59-74. doi: 10.1016/S0163-4453(09)60009-8.
Zotero 插件